Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectom...

Full description

Saved in:
Bibliographic Details
Published inClinical case reports Vol. 10; no. 11; pp. e6599 - n/a
Main Authors Nefiss, Mouadh, Abid, Hichem, Gharbi, Mohamed Amine, Bouzidi, Ramzi, Teborbi, Anis
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.11.2022
John Wiley and Sons Inc
Wiley
Subjects
bone metastases
Case Report
Case reports
Chemotherapy
Consent
Embolization
Immunotherapy
Kidney cancer
Medical imaging
Medical prognosis
Metastasis
Multidisciplinary teams
Patients
Quality of life
Radiation therapy
renal cell carcinoma
Surgery
targeted therapy
Young adults
bone metastases
targeted therapy
renal cell carcinoma
surgery
Online AccessGet full text
ISSN2050-0904
2050-0904
DOI10.1002/ccr3.6599

Cover

More Information
Summary:Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis. Associated to targeted therapy, surgery is a good option to reach curative outcome, achieve local tumor control, and increase survival in case of solitary or limited number of metastases from renal cell carcinoma.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
content type line 23
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.6599